NKF-K/DOQI.Clinical Practice Guidelines for Bone Metabolism and Disease in
Chronic Kidney Di sease. Background.AJKD2003; 42(Suppl.)3:
S29–44.
2.
BrownE.M.Four-parameter model of the sigmoidal relationship between
parathyroid hormone release and extracellular calcium concentration in
normal and abnormal parathyroid tissue.J Clin Endocrinol Metab1983, 56:
572–81.
AmbroginiE.,
CetaniF.,
MarcocciC.Osteoporosi e iperparatiroidismo.Riv It Ost Gin2005; 5–6:
278–85.
5.
KhanA.,
BilezikianJ.,
Primary hyperparathyroidism: pathophysiology and impact
bone.CMAJ2000; 163(2):
173–5.
6.
LocatelliF.,
PontorieroG.,
LimardoM.Introduzione: i calciomimetici nell'iperparatiroidismo primitivo
e secondario.Giornale di Tecniche Nefrologiche & Dialitiche2009; 1.
7.
Kalantar
ZadehK.,
KuwaeN.,
RegidorD.L..
Survival predictability of time-varying indicators of bone
disease in maintenance hemodialysis patients.Kidney Int2006; 70(4):
771–80.
